Ledger.Open graph →
SEC Form D · Amendment · filed February 3, 2021

Nine Square Therapeutics Corp

Offering
$50.0M
Sold
$4.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Matthew Jacobson · Lewiston, MEDirectorSeth Harrison · Cambridge, MADirectorSpiros Liras · New York, NYExec · DirectorMichael Ehlers · New York, NYDirectorMatthew Jacobson · PORTLAND, ORDirectorSeth Harrison · New York, NYDirectorSpiros Liras · New York, NYExec · DirectorMichael Ehlers · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗